Rocket Pharmaceuticals (RCKT) Change in Account Payables (2014 - 2017)
Rocket Pharmaceuticals (RCKT) reported Change in Account Payables of $68000.0 for Q4 2017, up 136.76% on a YoY basis from $28721.5 in Q4 2016, and up 353.33% sequentially from $15000.0 in Q3 2017.
Rocket Pharmaceuticals (RCKT) Change in Account Payables (2014 - 2017) Analysis & Trends
Rocket Pharmaceuticals (RCKT) has 4 years of Change in Account Payables data on file, last reported at $68000.0 in Q4 2017.
- For the quarter ending Q4 2017, Change in Account Payables rose 136.76% year-over-year to $68000.0; the trailing twelve-month figure through Dec 2017 stood at -$1.1 million (down 2682.93% YoY), and the FY2017 full-year result was -$1.1 million, down 2682.93% from the prior year.
- Change in Account Payables improved to $68000.0 in Q4 2017, from $15000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $896000.0 in Q3 2015 to a low of -$1.5 million in Q2 2017.
- A 4-year average of $13875.0 and a median of $41500.0 in 2017 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 527.78% in 2015, while the deepest fall reached 393.37% in 2015.
- Tracing RCKT's Change in Account Payables over 4 years: stood at $98000.0 in 2014, then plunged by 177.55% to -$76000.0 in 2015, then plunged by 143.42% to -$185000.0 in 2016, then soared by 136.76% to $68000.0 in 2017.
- Business Quant data shows RCKT's Change in Account Payables at $68000.0 in Q4 2017, $15000.0 in Q3 2017, and -$1.5 million in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Rocket Pharmaceuticals | 357.93 Mn | 357.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 68,000.00 |
| Dec 31, 2017 | 68,000.00 |
| Sep 30, 2017 | 15,000.00 |
| Sep 30, 2017 | 15,000.00 |
| Jun 30, 2017 | -1.53 Mn |
| Jun 30, 2017 | -1.53 Mn |
| Mar 31, 2017 | 310,000.00 |
| Mar 31, 2017 | 310,000.00 |
| Dec 31, 2016 | -185,000.00 |
| Dec 31, 2016 | -185,000.00 |
| Sep 30, 2016 | 856,000.00 |
| Sep 30, 2016 | 856,000.00 |
| Jun 30, 2016 | -455,000.00 |
| Jun 30, 2016 | -455,000.00 |
| Mar 31, 2016 | -257,000.00 |
| Mar 31, 2016 | -257,000.00 |
| Dec 31, 2015 | -76,000.00 |
| Dec 31, 2015 | -76,000.00 |
| Sep 30, 2015 | 896,000.00 |
| Sep 30, 2015 | 896,000.00 |